Stuart Hinchen will succeed Peter Jenkins as chief executive officer of JHP Pharmaceuticals effective July 1, 2011. Mr. Hinchen has acted as JHP’s president and chief operating officer since the formation of the company in 2007. Mr. Jenkins commented, “Over the past four years we have established JHP on a secure financial and operational basis with growing revenues and strong profitability as well as put in place an assured platform for growth in both our marketed products and contr...